Startseite Sodium and risk assessment of osmotic demyelination syndrome: the method matters!
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Sodium and risk assessment of osmotic demyelination syndrome: the method matters!

  • Veronique V. Stove , Matthijs Oyaert und Joris R. Delanghe ORCID logo EMAIL logo
Veröffentlicht/Copyright: 27. Juli 2023
Veröffentlichen auch Sie bei De Gruyter Brill

Received: 2023-06-28
Accepted: 2023-07-15
Published Online: 2023-07-27
Published in Print: 2024-01-26

© 2023 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Biological management of diabetes mellitus, the laboratory medicine specialist and the patient
  4. Reviews
  5. Remote HbA1c testing via microsampling: fit for purpose?
  6. The effect of hormonal contraceptive therapy on clinical laboratory parameters: a literature review
  7. Opinion Paper
  8. Continuous glucose monitoring has an increasing role in pre-symptomatic type 1 diabetes: advantages, limitations, and comparisons with laboratory-based testing
  9. IFCC Paper
  10. Comparison and commutability study among four faecal immunochemical tests (FIT) systems
  11. Guidelines and Recommendations
  12. Evidence-based procedures to improve the reliability of circulating miRNA biomarker assays
  13. General Clinical Chemistry and Laboratory Medicine
  14. Commutability assessment of candidate reference materials for plasma renin activity measurement: current challenges
  15. Aggregated data from the same laboratories participating in two glucose external quality assessment schemes show that commutability and transfers of values to control materials are decisive for the biases found
  16. Methodological considerations in determining sex steroids in children: comparison of conventional immunoassays with liquid chromatography-tandem mass spectrometry
  17. From “wet” matrices to “dry” blood spot sampling strategy: a versatile LC-MS/MS assay for simultaneous monitoring caffeine and its three primary metabolites in preterm infants
  18. A sensitive LC-MS/MS methotrexate assay capable of assessing adherence to methotrexate therapy in rheumatoid arthritis
  19. Determination of cortisone and cortisol in human scalp hair using an improved LC-MS/MS-based method
  20. Mild hypophosphatasia may be twice as prevalent as previously estimated: an effective clinical algorithm to detect undiagnosed cases
  21. Combined deficient response to polysaccharide-based and protein-based vaccines predicts a severe clinical phenotype
  22. Reference Values and Biological Variations
  23. A sex-specific association of leukocyte telomere length with thigh muscle mass
  24. Cancer Diagnostics
  25. Optimized procedure for high-throughput transcriptome profiling of small extracellular vesicles isolated from low volume serum samples
  26. Ultra-short cell-free DNA fragments enhance cancer early detection in a multi-analyte blood test combining mutation, protein and fragmentomics
  27. Clinical relevance of clonal hematopoiesis and its interference in cell-free DNA profiling of patients with gastric cancer
  28. Development and analytical validation of a novel nasopharynx swab-based Epstein-Barr virus C promoter methylation quantitative assay for nasopharyngeal carcinoma detection
  29. Infectious Diseases
  30. (Pre)analytical considerations concerning the analysis of synovial calprotectin
  31. Corrigendum
  32. Thermal and chronological stability of monocyte distribution width (MDW), the new biomarker for sepsis
  33. Acknowledgment
  34. Acknowledgment
  35. Letters to the Editor
  36. In-house diagnostic devices under the EU IVDR and unwanted side-effects of intentional transparency
  37. Use of thyroid function tests in urine: a position statement of the Belgian Thyroid Club
  38. State of the art of measurement uncertainty of serum ferritin
  39. Analytical performance evaluation and consumable waste reduction strategies using a tube-based quality control material
  40. Stability of fecal calprotectin extracts using the Diasorin® kit
  41. Reverse cascade testing from newborn screening: the opportunity to improve family healthcare outcomes
  42. An indirect data-mining approach to standardise paediatric serum phosphate reference intervals in Wales
  43. Sodium and risk assessment of osmotic demyelination syndrome: the method matters!
Heruntergeladen am 21.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/cclm-2023-0667/html?lang=de
Button zum nach oben scrollen